Intelligent Bio Solutions Inc. Files 8-K

Ticker: INBS · Form: 8-K · Filed: Jul 15, 2025 · CIK: 1725430

Sentiment: neutral

Topics: corporate-filing, regulation-fd, financials

TL;DR

IBSI filed an 8-K on 7/15/25, check for updates.

AI Summary

Intelligent Bio Solutions Inc. filed an 8-K on July 15, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, formerly known as GBS Inc. and Glucose Biosensor Systems (Greater China) Holdings, Inc., is incorporated in Delaware and headquartered in New York.

Why It Matters

This filing indicates a routine corporate disclosure, potentially containing updates on financial status or significant business events that could impact investors.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for corporate reporting and does not appear to contain immediate negative news.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

This 8-K filing serves as a Current Report for Intelligent Bio Solutions Inc., covering Regulation FD Disclosure and Financial Statements and Exhibits, filed on July 15, 2025.

What were the previous names of Intelligent Bio Solutions Inc.?

Intelligent Bio Solutions Inc. was formerly known as GBS Inc. and prior to that, Glucose Biosensor Systems (Greater China) Holdings, Inc.

When was the company incorporated and where is its principal executive office located?

The company is incorporated in Delaware and its principal executive offices are located at 135 West 41st Street, 5th Floor, New York, NY 10036.

What is the SIC code for Intelligent Bio Solutions Inc.?

The Standard Industrial Classification (SIC) code for Intelligent Bio Solutions Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.

What is the fiscal year end for Intelligent Bio Solutions Inc.?

The fiscal year end for Intelligent Bio Solutions Inc. is June 30.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 15, 2025 regarding INTELLIGENT BIO SOLUTIONS INC. (INBS).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing